Darrel Wright Hunt, | |
2525 King Ave W, Billings, MT 59102-6425 | |
(406) 203-6258 | |
Not Available |
Full Name | Darrel Wright Hunt |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 2525 King Ave W, Billings, Montana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538808993 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | PHA-PHA-LIC-85717 (Montana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Darrel Wright Hunt, 2525 King Ave W, Billings, MT 59102-6425 Ph: () - | Darrel Wright Hunt, 2525 King Ave W, Billings, MT 59102-6425 Ph: (406) 203-6258 |
News Archive
An interdisciplinary, city-wide consortium of researchers, led by Alan E. Greenberg, MD, MPH, professor and chair, Department of Epidemiology and Biostatistics at Milken Institute School of Public Health (Milken Institute SPH) at the George Washington University, has received a grant from the National Institutes of Health for an expected $7.5 million over five years to fund the newly established District of Columbia Center for AIDS Research.
Researchers from UCLA's Jonsson Comprehensive Cancer Center have developed an innovative cancer-fighting technique in which custom-designed nanoparticles carry chemotherapy drugs directly to tumor cells and release their cargo when triggered by a two-photon laser in the infrared red wavelength.
A modified form of poliovirus, pioneered at Duke Cancer Institute as a therapy for glioblastoma brain tumors, appears in laboratory studies to also have applicability for pediatric brain tumors when used as part of a cancer vaccine.
Cancer Research Institute, Inc. (CRI), a U.S. nonprofit organization founded in 1953 to advance the science of tumor immunology and foster the discovery and development of new cancer immunotherapies, announced today that its Cancer Vaccine Acceleration Fund (CVAF), a joint initiative with the Ludwig Institute for Cancer Research (LICR), has completed a new investment agreement with Oncovir, Inc., a biotechnology company based in Washington, D.C., to enable the production of the immunological stimulant Hiltonol® (Poly-ICLC).
› Verified 8 days ago
Hannah Elizabeth Johnson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1649 Main St, Billings, MT 59105 Phone: 406-254-2842 | |
David Sanks, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2525 King Ave W, Billings, MT 59102 Phone: 406-652-9688 | |
Joshua Teynor, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1602 Main St, Billings, MT 59105 Phone: 406-245-0178 | |
Gerald Robbin Fisher, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3333 Grand Ave, Billings, MT 59102 Phone: 406-652-1620 | |
Dr. Natalie Marie Waterfall, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 670 Main St, Billings, MT 59105 Phone: 406-245-6979 | |
Barbara Metzger, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2290 King Ave W, Billings, MT 59102 Phone: 406-656-8556 | |
Kailey Klinger, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1775 Spring Creek Lane, Billings, MT 59102 Phone: 406-373-3500 Fax: 406-373-3607 |